Atrial fibrillation

Last updated: June 11, 2026

Atrial fibrillation

Watch later

Watch later

Coronary artery disease: Clinical
Inflammatory bowel disease: Pathology review
Crohn disease
Ulcerative colitis
Inflammatory bowel disease: Clinical
Macrocytic anemia: Pathology review
Anemia: Clinical
Extrinsic hemolytic normocytic anemia: Pathology review
Microcytic anemia: Pathology review
Sideroblastic anemia
Autoimmune hemolytic anemia
Iron deficiency anemia
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Anemia of chronic disease
Folate (Vitamin B9) deficiency
Pancreatitis: Pathology review
Pancreatitis: Clinical
Acute pancreatitis
Chronic pancreatitis
Superior mesenteric artery syndrome
Diverticulosis and diverticulitis
Diverticular disease: Pathology review
Diverticular disease: Clinical
Appendicitis: Clinical
Appendicitis
Appendicitis: Pathology review
Irritable bowel syndrome
Anatomy of the abdominal viscera: Large intestine
Vitamin B12 deficiency
Myocardial infarction
ECG cardiac infarction and ischemia
Clot retraction and fibrinolysis
Platelet plug formation (primary hemostasis)
Erythropoietin
Coagulation (secondary hemostasis)
Atrial fibrillation
Anticoagulants: Warfarin
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Ventricular fibrillation
Ventricular tachycardia
Class III antiarrhythmics: Potassium channel blockers
Atrial flutter
Ventricular arrhythmias: Pathology review
Supraventricular arrhythmias: Pathology review
Acute kidney injury: Clinical
Kidney stones: Pathology review
Kidney stones
Glomerular filtration
Long QT syndrome and Torsade de pointes
Hyperkalemia
Hyperkalemia: Clinical
Chronic kidney disease
Chronic kidney disease: Clinical
Hyperphosphatemia
Hypercalcemia
Kidney stones: Clinical
Renal failure: Pathology review
Diabetes mellitus: Clinical
Metabolic acidosis
Class I antiarrhythmics: Sodium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class II antiarrhythmics: Beta blockers
Positive inotropic medications
Hyponatremia: Clinical
Hyponatremia
Hypernatremia: Clinical
Hypernatremia
Chronic obstructive pulmonary disease (COPD): Clinical
Obstructive lung diseases: Pathology review
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Emphysema
Pulmonary hypertension
Cor pulmonale
Chronic bronchitis
Muscarinic antagonists
Asthma: Clinical
Asthma
Pulmonary embolism
Deep vein thrombosis and pulmonary embolism: Pathology review
Venous thromboembolism: Clinical
Pneumonia: Pathology review
Pneumonia
Pneumonia: Clinical
Ventilation-perfusion ratios and V/Q mismatch
Shock: Clinical
Shock: Pathology review
Shock
Factor V Leiden
Anticoagulants: Heparin
Hyperthyroidism medications
Hyperthyroidism: Pathology review
Hyperthyroidism: Clinical
Hypothyroidism and thyroiditis: Clinical
Hypothyroidism: Pathology review
Hypothyroidism medications
Pheochromocytoma
Adrenal masses: Pathology review
Renal artery stenosis
Hyperaldosteronism
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome: Clinical
Diabetes insipidus and SIADH: Pathology review
Pericardial disease: Clinical
Dementia and delirium: Clinical
Dementia with Lewy bodies
Alzheimer disease
Parkinson disease
Anti-parkinson medications
Traumatic brain injury: Clinical
Concussion and traumatic brain injury
Brown-Sequard Syndrome
Cauda equina syndrome
Meningitis
Myasthenia gravis
Multiple sclerosis
Stroke: Clinical
Cerebral vascular disease: Pathology review
Alcohol use disorder
Seizures: Clinical

Transcript

Watch video only

Atrial fibrillation, sometimes called Afib for short, is the most common cardiac arrhythmia, which occurs when the atria contract way faster than expected and in a disorganized manner. As a result, the atria have a quivering or twitching movement that can’t pump blood into the ventricles efficiently.

Now, let’s cover some physiology of the cardiac conduction system. The cardiac conduction system is made up of specialized myocardial cells that can create and transport electrical potential, also called an action potential. These cells have many special features, including automaticity, meaning that they can generate an impulse; excitability, which is the ability to respond to a stimulus by creating an electrical impulse; conductivity meaning they can carry the impulse to other cells; and contractility, which is the ability to shorten the length of their fibers, causing a contraction.

Alright, now let’s look at the normal electrical conduction pathway in the heart on an ECG, which shows how the depolarization wave flows through the heart during each heartbeat. The normal electrical activity of the heart starts in the sinoatrial or SA node, which is considered the pacemaker of the heart.

Then, the impulse is conducted through the atria , causing depolarization and creating the P wave on an ECG. When the atrial muscle cells get depolarized, they contract, pushing blood from the atria into the ventricles.

From the atria, the impulse goes to the atrioventricular, or AV node, where the impulse propagation speed slows way down. The interval from the atrial depolarization to just before ventricular depolarization is the PR interval on an ECG. This delay allows the atria to

contract while the ventricles fill with blood.

From the AV node, the impulse goes through the Bundle of His, then to the right and left bundle branches, and finally through the Purkinje fibers, which deliver the impulse to the right and left

ventricles, causing them to depolarize, and is represented by the QRS complex on an ECG. This triggers simultaneous contraction of both ventricles, pushing blood into the systemic and pulmonary circulations. Finally, the ventricles repolarize to prepare for the next cycle, which allows them to relax and fill with blood, called diastole. And on ECG, ventricular repolarization will create a T wave, while the phase between ventricular depolarization and repolarization is represented by the ST segment. Sometimes, immediately after the T wave, there’s a U wave, which represents late repolarization of the ventricles.

Okay, now, atrial fibrillation is typically caused by any kind of structural damage to the heart or any damage to the heart's electrical conduction system. Often, these changes are strongly associated with several cardiovascular disorders and risk factors. For example, high blood pressure, coronary artery disease, valvular diseases, essentially anything that can create an inflammatory state or physically stretches the atria, may potentially damage the cells in the atria and lead to atrial fibrillation.

Other risk factors include older age, and a family history of heart disease or atrial fibrillation; as well as sleep apnea, obesity, diabetes, thyrotoxicosis, which means excess levels of thyroid hormones; and excessive alcohol consumption.

These factors likely stress and damage the cells in the atria, which can lead to tissue heterogeneity; in other words, cells start taking on different electrical properties, generating impulses from many foci in a totally disorganized manner,

which tends to override the sinoatrial node. So instead of one efficient atrial contraction, clients get all these mini contractions, usually between 350 and 600 per minute, that make it look like the atria are just quivering.

Sometimes, signals from one of these areas make it down to the ventricles and cause irregular ventricular contraction; these QRS complexes are interspersed at irregular intervals, though, and usually at high rates, between 100 and 150 beats per minute. As a result, the ventricular filling is also impaired, which reduces cardiac output.

Additionally, the inefficient emptying of the atria into the ventricles can cause blood to stay in the atria for longer than usual, allowing it to form atrial clots. This is especially concerning in the left atrium, which has a small pocket where the blood can collect, and clots are most likely to form. So, with atrial fibrillation, there’s a chance that one of these clots can get pumped from the atria into the ventricles, and from there, into the systemic circulation.

From there, the clot can get lodged in a cerebral artery, causing a stroke, or in other systemic arteries, blocking blood flow to areas such as the kidney, spleen, or extremities.

Often, people with atrial fibrillation start by experiencing paroxysmal events, which means AFib suddenly comes and goes, lasting less than a week at a time, probably because the tissue is still relatively healthy. Repeated paroxysmal events over extended periods stress the atrial cells even more. Over time, the cells in the atrium undergo progressive fibrosis or scarring, which means the AFib episodes didn’t terminate spontaneously in less than a week.

AFib episodes that last longer than one week are called persistent AFib; when it lasts for more than 12 months, it’s called long-standing persistent AFib. Finally, when long-standing persistent AFib is left untreated or doesn’t respond to treatment, that’s called permanent atrial fibrillation; in time, it can lead to heart failure.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Atrial Fibrillation" Annals of Internal Medicine (2017)
  5. "Atrial fibrillation" Journal of Biomedical Research (2014)
  6. "Risk Factors and Genetics of Atrial Fibrillation" Cardiology Clinics (2014)
  7. "Atrial Fibrillation" Circulation Research (2017)
  8. "Critical care nursing: Diagnosis and management (10th ed.) ISBN: 978-0-443-11581-3 " Elsevier (2026)
  9. "Lewis’s Medical-Surgical Nursing: Assessment and Management of Clinical Problems. 12th Edition. ISBN:978-0-323-78961-5 " Elsevier
  10. "Guyton and Hall Textbook of Medical Physiology. ISBN 978-0323597128 " Elsevier (2020)
  11. "Mosby’s® Diagnostic and Laboratory Test Reference. 15th edition. ISBN: 978-0-323-67519-2 " Mosby (2020 )
  12. "Fundamentals of Nursing. 11th edition. ISBN: 978-0-323-81034-0 " Elsevier (2022)
  13. "Atrial Fibrillation: Pathogenesis, Predisposing Factors, and Genetics. 23(1):6." Int J Mol Sci (2021 Dec 21)
  14. "Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights. 127(1):4-20. " Circ Res. (2020)
  15. "Mortality in atrial fibrillation. Is it changing?. 31(8):469-473." Trends Cardiovasc Med. (2021)